Drägerwerk stock reports stronger margins after H1 EBIT gains
Published on 09/29/2026 at 12:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Drägerwerk stock (ISIN DE0005550636) was trading at EUR 123.20 at Lang & Schwarz on September 29, 2026 at 12:22 p.m. CEST, down 0.96 percent versus the Xetra close of EUR 124.40 on September 28, 2026. The central investor issue is whether the medical and safety technology group can convert stronger first-half profitability into a sustained margin improvement.
EBIT more than tripled
According to Yahoo Finance on July 30, 2026, Dräger reported first-half 2026 net sales of EUR 1.6 billion and EBIT of EUR 64 million, compared with EUR 20 million in the prior-year period. The EBIT margin consequently rose to 4.0 percent from 1.3 percent.
The comparison is important because the improvement was not limited to sales. Yahoo Finance reported that first-half order intake reached EUR 1.75 billion, up 1.8 percent year over year, while gross margin increased by 1.7 percentage points to 46.5 percent.
Target moves above the quote
The valuation reference moved higher in the latest analyst update. mwb research raised its price target from EUR 114.00 to EUR 130.00 on August 31, 2026, and reiterated a Buy rating. The new target lies 5.52 percent above the Lang & Schwarz price.
The operating mix adds context to that view. Safety division EBIT increased from EUR 54 million to EUR 78 million in the first half, while Medical division EBIT improved from minus EUR 33.7 million to minus EUR 14.3 million, according to Yahoo Finance. Medical therefore remains loss-making, but its deficit narrowed by EUR 19.4 million year over year.
Next results set for October
The next scheduled checkpoint is the Q3 2026 earnings release on October 29, 2026, listed by Marketscreener. Dräger also plans a Capital Markets Day on November 18, 2026, where management is expected to detail its medium-term profitability strategy.
Stock stays below yearly high
The 52-week range was EUR 62.50 to EUR 125.40 as of September 29, 2026. At EUR 123.20, the stock stood EUR 2.20 below the high, while its intraday quote was EUR 0.96 below the Xetra close used for the comparison.
Drägerwerk stock facts on September 29, 2026
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- WKN: 555063
- Ticker: DRW3
- Primary exchange: Xetra
- Price Lang & Schwarz (as of September 29, 2026, 12:22 p.m. CEST): EUR 123.20
- Change versus Xetra close: minus 0.96 percent
- Xetra close (September 28, 2026): EUR 124.40
- Market capitalization: EUR 2.3 billion (as of September 29, 2026)
- 52-week range: EUR 62.50-EUR 125.40 (as of September 29, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: SDAX and TecDAX
- Next earnings date: October 29, 2026
